title: [Ferritin, oxidative stress and coronary atherosclerosis].
abstract: OBJECTIVE
  In the recent years several studies showed the association between body iron stores, represented by serum ferritin, and atherosclerosis. It was proposed that iron bound to ferritin catalyzes the formation of highly reactive forms of oxygen free radicals which subsequently cause the oxidative modification of atherogenic lipoproteins. Aim of our study was to compare serum ferritin concentrations and certain markers of oxidative stress in patients with and without coronarographically assessed coronary vascular disease.
  
  
  RESULTS
  Measurements were performed in 216 subjects at the age of 35-60 years. The patient group included 76 patients with coronarographically assessed coronary vascular disease (CVD) (mean age 51.16 +/- 5.713 years) and 140 healthy controls (mean age 50.21 +/- 5.331 years). The plasma concentration of ferritin was higher in patients (169.04 +/- 63.899 micrograms/l) than controls (87.70 +/- 41.394 micrograms/l), p < 0.001. The group of patients revealed significantly lower plasma concentrations of anti-oxLDL antibodies, nitrites/nitrates, tocopherol and high density lipoprotein cholesterol (HDL-cholesterol) than controls; on the contrary patients had significantly higher concentrations of hemoglobin, thrombocytes and triacylglycerols. In the whole cohort of investigated subjects, ferritin correlated positively with retinol, body mass index (BMI), total-cholesterol, triacylglycerols, low density lipoprotein cholesterol (LDL-cholesterol), blood glucose, creatinine, uric acid, alaninaminotransferase (ALT), aspartateaminotransferase (AST), hematocrite, erythrocytes, with occurrence of CVD and with sex. Inverse correlation was observed between ferritin and HDL-cholesterol.
  
  
  CONCLUSIONS
  Our observations are consistent with the hypothesis that high stored iron levels, measured by serum ferritin concentrations, may contribute to the oxidative stress and thus elevate the risk for development of CVD.
authors.affiliation: 2. interní klinika 3. lékarské fakulty UK a FN Královské Vinohrady, Praha.
authors.forename: P
authors.initials: P
authors.lastname: Kraml
authors.forename: J
authors.initials: J
authors.lastname: Potocková
authors.forename: H
authors.initials: H
authors.lastname: Koprivová
authors.forename: S
authors.initials: S
authors.lastname: Stípek
authors.forename: J
authors.initials: J
authors.lastname: Crkovská
authors.forename: T
authors.initials: T
authors.lastname: Zima
authors.forename: M
authors.initials: M
authors.lastname: Andĕl
mesh_terms: D000328:Adult; D000906:Antibodies / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood*; D005260:Female; D005293:Ferritins / Q000097:blood*; D006801:Humans; D008077:Lipoproteins, LDL / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009566:Nitrates / Q000097:blood; D009573:Nitrites / Q000097:blood; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D012307:Risk Factors
chemical_list: D000906:Antibodies; D008077:Lipoproteins, LDL; D009566:Nitrates; D009573:Nitrites; C099252:oxidized low density lipoprotein; D005293:Ferritins